News
Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due to ...
The deal settles Credit Suisse’s outstanding obligations relating to mortgage-backed bonds sold before the 2008 financial ...
CNBC's "Fast Money" team is joined by Evan Brown, head of multi-asset strategy at UBS Asset Management, to discuss why he ...
UBS Group AG is sounding out investors for a potential significant risk transfer, according to people familiar with the ...
Friday's jobs data and revisions gave investors a lot to digest. While stocks fell at first in response to the weakening labor market, they rebounded after expectations for interest-rate cuts grew. Th ...
Bloom Energy Corporation (NYSE:BE) is one of the 12 Best Performing AI Stocks So Far in 2025. On July 25, UBS increased its ...
UBS has agreed to pay $300mn to resolve a legacy Credit Suisse case in the US related to the mis-selling of residential ...
UBS kicked off coverage with a ‘buy’ rating on power generation players BHEL, Waaree Energies, Premier Energies, and Suzlon ...
UBS AG today published its second-quarter 2025 consolidated financial report. UBS Group AG previously reported its second-quarter results 2025 on a consolidated basis on 30 July 2025. These reports ...
UBS's second-quarter profit more than doubled from a year earlier, beating expectations on a surge in trading activity even ...
Investors in those bonds are suggesting global economic growth of more than 5% this year, which is higher than what most ...
A sweeping July 2025 report from UBS Evidence Lab highlights that artificial intelligence, and generative AI in particular, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results